戻る
Chugai Pharmaceutical Co., Ltd. (CHGCF)価格
CHGCF 株価推移チャート
CHGCF 収入
Chugai Pharmaceutical Co., Ltd.
$57.59
-1.62%
$-0.94
本日現在の状況：Jan 28, 12:24:09 GMT-5
最新の利益結果: Q3 '25
報告済み: 2025-10-24
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
CHGCFの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Chugai Pharmaceutical Co., Ltd. CHGCFの前四半期の収益はどうでしたか？
Chugai Pharmaceutical Co., Ltd.の収益見積もりはいくらですか？
Chugai Pharmaceutical Co., Ltd.の収益品質スコアはどれくらいですか？
Chugai Pharmaceutical Co., Ltd.はいつ収益を報告しますか？
Chugai Pharmaceutical Co., Ltd.の予想収益はいくらですか？
Chugai Pharmaceutical Co., Ltd.は収益予想を上回りましたか？
主要データ
前終値
$58.54
始値
$57.61
当日レンジ
$57.59 - $57.61
52週レンジ
$32.25 - $72.3
取引高
1.5K
平均取引高
2.0K
1株当たり利益(TTM)
1.53
配当利回り
--
時価総額
$94.7B
CHUGAI PHARMACEUTICAL COとは何ですか？
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 7,778 full-time employees. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The firm is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The firm operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.